Entries of Bargou, Ralf C. on the publication server
![]() | Up a level |
Number of items: 6.
2020
Gökbuget, Nicola, Zugmaier, Gerhard, Dombret, Hervé, Stein, Anthony, Bonifacio, Massimiliano, Graux, Carlos, Faul, Christoph, Brüggemann, Monika, Taylor, Kate, Mergen, Noemi, Reichle, Albrecht, Horst, Heinz-August, Havelange, Violaine, Topp, Max S. and Bargou, Ralf C.
(2020)
Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia.
Leukemia & Lymphoma 61 (11), pp. 2665-2673.
Fulltext not available.
2019
Knop, Stefan, Engelhardt, Monika, Liebisch, Peter, Meisner, Christoph, Holler, Ernst, Metzner, Bernd, Peest, Dietrich, Kaufmann, Martin, Bunjes, Donald, Straka, Christian, Fischer, Thomas, Sezer, Orhan, Hentrich, Marcus, Ostermann, Helmut, Bassermann, Florian, Hess, Georg, Hertenstein, Bernd, Freund, Mathias, Kropff, Martin, Schmidt, Christian A., Wolf, Hans-Heinrich, Jung, Wolfram, Frickhofen, Norbert, Mielke, Stephan
, Bargou, Ralf C., Maschmeyer, Georg, Svaldi, Mirija, Langer, Christian H., Gramatzki, Martin, Hebart, Holger, Kanz, Lothar and Einsele, Hermann
(2019)
Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis.
Leukemia 33 (11), pp. 2710-2719.
Fulltext not available.
, Bargou, Ralf C., Maschmeyer, Georg, Svaldi, Mirija, Langer, Christian H., Gramatzki, Martin, Hebart, Holger, Kanz, Lothar and Einsele, Hermann
(2019)
Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis.
Leukemia 33 (11), pp. 2710-2719.
Fulltext not available.
2018
Bargou, Ralf C., Nagorsen, Dirk, Zugmaier, Gerhard, Benjamin, Jonathan E., Haddad, Vincent, Wessels, Hendrik, Stieglmaier, Julia, Havelange, Violaine, Horst, Heinz-August, Brüggemann, Monika, Topp, Max S., Diedrich, Helmut, Faul, Christoph, Graux, Carlos, Reichle, Albrecht, Bonifacio, Massimiliano, Dombret, Hervé and Gökbuget, Nicola
(2018)
Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia.
Blood 131 (14), pp. 1522-1531.
Fulltext not available.
2016
Schoffer, Olaf, Schülein, Stefanie, Arand, Gerlinde, Arnholdt, Hans, Baaske, Dieter, Bargou, Ralf C., Becker, Nikolaus, Beckmann, Matthias W., Bodack, Yves, Böhme, Beatrix, Bozkurt, Tayfun, Breitsprecher, Regine, Buchali, Andre, Burger, Elke, Burger, Ulrike, Dommisch, Klaus, Elsner, Gudrun, Fernschild, Karin, Flintzer, Ulrike, Funke, Uwe, Gerken, Michael, Göbel, Hubert, Grobe, Norbert, Gumpp, Vera, Heinzerling, Lucie, Kempfer, Lana Raffaela, Kiani, Alexander, Klinkhammer-Schalke, Monika, Klöcking, Sabine, Kreibich, Ute, Knabner, Katrin, Kuhn, Peter, Lutze, Stine, Mäder, Uwe, Maisel, Tanja, Maschke, Jan, Middeke, Martin, Neubauer, Andreas, Niedostatek, Antje, Opazo-Saez, Anabelle, Peters, Christoph, Schell, Beatrice, Schenkirsch, Gerhard, Schmalenberg, Harald, Schmidt, Peter, Schneider, Constanze, Schubotz, Birgit, Seide, Anika, Strecker, Paul, Taubenheim, Sabine, Wackes, Matthias, Weiß, Steffen, Welke, Claudia, Werner, Carmen
, Wittekind, Christian, Wulff, Jörg, Zettl, Heike and Klug, Stefanie J.
(2016)
Tumour stage distribution and survival of malignant melanoma in Germany 2002–2011.
BMC Cancer 16 (1).
2015
Zugmaier, Gerhard, Gökbuget, Nicola, Klinger, Matthias, Viardot, Andreas, Stelljes, Matthias, Neumann, Svenja, Horst, Heinz-A., Marks, Reinhard, Faul, Christoph, Diedrich, Helmut, Reichle, Albrecht, Brüggemann, Monika, Holland, Chris, Schmidt, Margit, Einsele, Hermann, Bargou, Ralf C. and Topp, Max S.
(2015)
Long-term survival and T-cell kinetics in relapsed/refractory ALL patients who achieved MRD response after blinatumomab treatment.
Blood 126 (24), pp. 2578-2584.
Fulltext not available.
2014
Topp, Max S., Gökbuget, Nicola, Zugmaier, Gerhard, Klappers, Petra, Stelljes, Matthias, Neumann, Svenja, Viardot, Andreas, Marks, Reinhard, Diedrich, Helmut, Faul, Christoph, Reichle, Albrecht, Horst, Heinz-August, Brüggemann, Monika, Wessiepe, Dorothea, Holland, Chris, Alekar, Shilpa, Mergen, Noemi, Einsele, Hermann, Hoelzer, Dieter and Bargou, Ralf C.
(2014)
Phase II Trial of the Anti-CD19 Bispecific T Cell–Engager Blinatumomab Shows Hematologic and Molecular Remissions in Patients With Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia.
Journal of Clinical Oncology 32 (36), pp. 4134-4140.
Fulltext not available.
